A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike BlakeNEW YORK, June 26 (Reuters) – Johnson & Johnson (JNJ.N) said on Saturday it will pay $263 million to resolve claims it fueled an opioid epidemic in New…

Click here to view the original article.